Robert Bruce's FATE Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 729.2K shares of Fate Therapeutics, Inc. (FATE) worth $918,777, representing 0.28% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 24 quarters.
Based on 13F filings, Robert Bruce has maintained a strategic position in FATE, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 300.0K shares. Largest reduction occurred in Q2 2025, reducing 120.8K shares.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's Fate Therapeutics (FATE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fate Therapeutics (FATE) Trades by Robert Bruce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2019 | +50,000 | New Buy | 50,000 | $19.56 |
| Q2 2020 | +50,000 | Add 100.00% | 100,000 | $34.31 |
| Q4 2020 | -25,000 | Reduce 25.00% | 75,000 | $90.92 |
| Q1 2021 | -10,000 | Reduce 13.33% | 65,000 | $82.45 |
| Q2 2021 | -3,000 | Reduce 4.62% | 62,000 | $86.77 |
| Q3 2021 | -5,000 | Reduce 8.06% | 57,000 | $59.26 |
| Q1 2023 | +143,000 | Add 250.88% | 200,000 | $5.70 |
| Q4 2023 | -57,000 | Reduce 28.50% | 143,000 | $3.74 |
| Q2 2024 | +157,000 | Add 109.79% | 300,000 | $3.28 |
| Q3 2024 | +50,000 | Add 16.67% | 350,000 | $3.50 |
| Q1 2025 | +200,000 | Add 57.14% | 550,000 | $0.79 |
| Q2 2025 | -120,812 | Reduce 21.97% | 429,188 | $1.12 |
| Q3 2025 | +300,000 | Add 69.90% | 729,188 | $1.26 |
Robert Bruce's Fate Therapeutics Investment FAQs
Robert Bruce first purchased Fate Therapeutics, Inc. (FATE) in Q4 2019, acquiring 50,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held Fate Therapeutics, Inc. (FATE) for 24 quarters since Q4 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's largest addition to Fate Therapeutics, Inc. (FATE) was in Q3 2025, adding 729,188 shares worth $918,777. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 729,188 shares of Fate Therapeutics, Inc. (FATE), valued at approximately $918,777. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Fate Therapeutics, Inc. (FATE) represents approximately 0.28% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's peak holding in Fate Therapeutics, Inc. (FATE) was 729,188 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.